Xponance’s SpringWorks Therapeutics SWTX Stock Holding History

Xponance’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,637	Closed	-$265K	–	1568
2025 Q2	$265K	Buy	5,637 +452	+9%	+$20.1K	﹤0.01%	1191
2025 Q1	$229K	Buy	+5,185	New	+$239K	﹤0.01%	1221
2024 Q2	–	Sell	-4,164	Closed	-$205K	–	1364
2024 Q1	$205K	Buy	+4,164	New	+$193K	﹤0.01%	1192

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Xponance's SWTX Position: Q3 2025 in Review

Xponance sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 5,637 shares — an estimated $265K sold.

Xponance first reported a position in SWTX in Q1 2024 and held it in 3 quarters. The position peaked at $265K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Xponance reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Xponance sold 5,637 SpringWorks Therapeutics shares in Q3 2025, an estimated $265K.
Xponance first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 3 quarters.
Xponance's SpringWorks Therapeutics position peaked at $265K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Xponance's 13F filing for Q3 2025, filed 12 Nov 2025.